Aurora Cannabis (ACB) Cost of Revenue (2017 - 2025)

Aurora Cannabis (ACB) has 9 years of Cost of Revenue data on file, last reported at $34.4 million in Q4 2025.

• Cost of Revenue for Q4 2025 came in at $34.4 million, up 7.2% year-over-year; the trailing twelve-month figure through Dec 2025 was $162.9 million (up 37.27% YoY), and the FY2025 annual result was $108.5 million, up 6.02% from the prior year.
• Cost of Revenue fell to $34.4 million in Q4 2025 per ACB's latest filing, from $39.8 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $100.8 million in Q1 2021 and troughed at -$179.3 million in Q2 2021.
• A 5-year average of $28.5 million and a median of $35.9 million in 2022 frame the typical range for Cost of Revenue.
• On a YoY basis, Cost of Revenue climbed as much as 209.64% in 2021 and fell as far as 182.04% in 2021.
• A 5-year view of Cost of Revenue shows it stood at $56.8 million in 2021, then dropped by 25.64% to $42.3 million in 2022, then retreated by 23.91% to $32.2 million in 2023, then declined by 0.13% to $32.1 million in 2024, then increased by 7.2% to $34.4 million in 2025.
• Business Quant data shows ACB's Cost of Revenue at $34.4 million in Q4 2025, $39.8 million in Q3 2025, and $44.8 million in Q2 2025.